An interventional study of surgical TAP block and US guided TAP block in Cesarean Section, Ultrasound Guided Transversus Abdominis Plane Block and Surgical Transversus Abdominis Plane Block, sponsored by Al-Azhar University. Recruiting at 1 site in Egypt. Open to female participants aged 21 Years to 35 Years. Per ClinicalTrials.gov, last updated 2026-01-06.
Sponsored by Al-Azhar University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 40 studies in Acute Pain with a site in Egypt — 6 open to participants now, 6 under way, none of them phase 3. Acute Pain · Egypt.
Among the 40 studies in Acute Pain with a site in Egypt, this one is the 32nd largest by planned enrollment, is one of 3 that started in 2023, is one of 28 with no phase, and was the 32nd registered.
1,077 studies on the registry are indexed under Acute Pain; 168 are open to participants now.
Browse Acute Pain studies →6 of the 40 studies in Acute Pain with a site in Egypt are open now. Recruiting first, the newest first:
Cairo University · Sites in Egypt
Ages 20–60 · Healthy volunteers
Mansoura University · Sites in Egypt
Ages 21–65 · Women only
South Egypt Cancer Institute · Sites in Egypt
Ages 18–70
Assiut University · Sites in Egypt
Ages 18–50
Mansoura University · Sites in Egypt
Ages 6–12
A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →
Of the 103 Acute Pain studies recruiting now, 40 (39%) set no upper age limit and 50 (49%) stop at 75 or younger; 21 take children under 18; 24 take healthy volunteers.
This study: 21 Years to 35 Years · female · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
40 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 3 · Phase 2 8 · Phase 3 4 · Phase 4 3
First in 2007; this study’s year is marked. 3 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 50 is below the median of 86 across 905 interventional studies indexed under Acute Pain.
Median enrollment 77 across the 40 interventional studies. Of the 24 that completed or were terminated, 1 (4%) have results posted.
This tab as a report to print or save as PDF → With an account.
2 of 40 have an industry lead sponsor. The 10 most frequent:
Al-Azhar University is the lead sponsor of 536 studies on the registry; 172 are open to participants now.
Of its 5 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Al-Azhar University has 1 study filed under Acute Pain — fewer than ten, so there is no comparison to draw.
2 of the studies in Acute Pain with a site in Egypt that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05750992Al-Azhar UniversityUltrasound Guided TAPB vs Surgical TAPB With Bupivacaine in Cesarean Section | 2026-12-30 |
| NCT06263907Mansoura UniversityStellate Ganglion Block for Prevention of Post Mastectomy Depression | 2027-11-30 |
Add all 2 to your calendar (.ics) → With an account.
Among the 40 studies in Acute Pain with a site in Egypt, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The aim of this study is to compare Surgical Transversus abdominis plane block and Ultrasound guided transversus abdominis plane block (TAPB) as a postoperative analgesic regimen in female patients undergoing elective cesarean delivery.
Caesarean delivery rates have been increasing worldwide nowadays. At rate of [52%], Egypt stands out among countries with the world's highest cesarean delivery percentages . Within the Arab region, rate of cesarean section far higher in Egypt than other Arab countries.
A much simpler and theoretically superior means of establishing a TAP block. When using a transcutaneous (conventional) approach there is always the risk of peritoneal puncture with its attendant complications. Moreover, there are technical difficulties, especially in obese women and the procedure requires specialist equipment, a skilled operator and training in ultrasonography. Our approach obviates these risks and difficulties because the procedure is carried out under direct vision, and it is much easier to perform by the surgeon during caesarean section.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
twenty-five pregnant women will receive surgical TAP block performed by 40 ml of 0.25% bupivacaine (10 ml 0.5% bupivacaine bilaterally diluted with 10cc normal saline and 100 μg of fentanyl), the total volume was divided equally and administered bilaterally by the surgeon.
Procedure: surgical TAP block
25 pregnant women will receive US guided T.A.P block performed by 40 ml of 0.25% bupivacaine (10 ml 0.5% bupivacaine bilaterally diluted with 10cc normal saline and 100 μg of fentanyl), the total volume was divided equally and administered bilaterally.
Procedure: US guided TAP block
performed by 40 ml of 0.25% bupivacaine (10 ml 0.5% bupivacaine bilaterally diluted with 10cc normal saline and 100 μg of fentanyl), the total volume was divided equally and administered bilaterally by the surgeon.
Also known as: bupivacaine, normal saline, fentanyl, pethidine
performed by 40 ml of 0.25% bupivacaine (10 ml 0.5% bupivacaine bilaterally diluted with 10cc normal saline and 100 μg of fentanyl), the total volume was divided equally and administered bilaterally.
Also known as: bupivacaine, normal saline, fentanyl , pethidine
Time to perform block.
The time taken to perform the block will be recorded by an independent observer.
Time frame: 1 hour postoperatively
Heart rate
Patients hemodynamics (heart rate will be recorded)
Time frame: 24 hours postoperatively
Mean arterial blood pressure
Patients hemodynamics (mean arterial blood pressure will be recorded)
Time frame: 24 hours postoperatively
Pain score
The Visual Analogue Scale (VAS) measures pain intensity. The VAS consists of a 10cm line, with two end points representing 0 ('no pain') and 10 ('pain as bad as it could possibly be').
Time frame: 24 hours postoperatively
Time to first analgesic request
The time to first analgesic request will be recorded
Time frame: 24 hours postoperatively
Amount of post operative analgesic consumption
The amount of post operative analgesic consumption will be recorded
Time frame: 24 hours postoperatively
Time spent in operating room
The time spent in operating room will be recorded
Time frame: 24 hours postoperatively
Incidence of Adverse reactions
Adverse events will be recorded such as nausea, vomiting, hypotension (Mean arterial blood pressure \< 20% of baseline readings and will be managed by ephedrine 5 mg IV and/or normal saline IV) and bradycardia (heart rate \< 60 beats/min and will be managed by atropine 0.6 mg IV).
Time frame: 24 hours postoperatively
Plan to share: Yes — The data will be available upon reasonable request from the principle investigator
Supporting information: Study protocol, Statistical analysis plan
Time frame: for one year after completion of the study
No publications or documents are linked to this record.
Started Apr 2023 (actual). Primary completion is estimated for Dec 2026, 44 months after the start.
Of 425 non-industry interventional studies with no phase under Acute Pain, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 23. This study's planned 44 months is above that.
Counting every sponsor, half of 431 studies reached it within 11 months; a quarter within 5 and three quarters within 23.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.